TonyFelefly Profile Banner
Tony Felefly Profile
Tony Felefly

@TonyFelefly

Followers
293
Following
1K
Media
29
Statuses
690

Radiation Oncologist | MSc Physics | PhD AI & Quantum Computing / Oncologic Imaging | Views are my own

Québec, Canada
Joined January 2012
Don't wanna be here? Send us removal request.
@TonyFelefly
Tony Felefly
19 hours
RT @dr_yakupergun: MATTERHORN: Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. https://t….
0
29
0
@TonyFelefly
Tony Felefly
23 hours
RT @StasLazarev: 👇Having treated multiple patients who developed radionecrosis after SRS for brain mets or after IMRT for high-grade glioma….
0
4
0
@TonyFelefly
Tony Felefly
1 day
RT @joshuapalmermd: Remarkable response to Boswellia after necrosis due to high dose brain SRS. In case you didn’t know I am a strong advo….
0
21
0
@TonyFelefly
Tony Felefly
2 days
RT @dr_alimuhammad: @TonyFelefly @jryckman3 One of the cases treated with 26Gy single fraction. One constraint we look at while evaluating….
0
1
0
@TonyFelefly
Tony Felefly
4 days
RT @drmikechao: @msam445 @jryckman3 @_ShankarSiva Thanks @msam445 .It’s now published. See CTRO Utilization of sHA spacer in SBRT for retro….
0
2
0
@TonyFelefly
Tony Felefly
4 days
RT @DrChoueiri: Today, serum KIM-1 is the biomarker to explore in all stages of RCC, via @eufocus . .
0
19
0
@TonyFelefly
Tony Felefly
5 days
RT @5_utr: ❗️ Important work for SCLC 1-10 brain mets -> SRS. mOS 10.2 m. Only 22% of patients needed salvage WBRT. Median 2 brain mets . h….
0
28
0
@TonyFelefly
Tony Felefly
6 days
RT @StAr_MCM74: @TonyFelefly @ESTRO_RT @5_utr The cumulative 10-yr incidence of late ≥G2 GU toxicity was 27% in the UHF group and 28% in th….
0
1
0
@TonyFelefly
Tony Felefly
6 days
RT @5_utr: Interesting work, but is benefit from CRT, IO, both? 🤷‍♂️.
0
1
0
@TonyFelefly
Tony Felefly
8 days
RT @DrewMoghanaki: John Belperio, division chief of pulmonology at UCLA, just shared an enlightening aphorism he learned from Steve Dubine….
0
3
0
@TonyFelefly
Tony Felefly
14 days
RT @dr_alimuhammad: Our article to look at the impact of tumour complexity on outcomes following SABR for primary kidney cancer.@_ShankarSi….
0
7
0
@TonyFelefly
Tony Felefly
16 days
RT @DrewMoghanaki: A link to download the Editorial of the Year is now available. @QuadShotNews .
0
9
0
@TonyFelefly
Tony Felefly
29 days
RT @SuyogCancer: 🚨 Just out in NEJM: #KEYNOTE689 💉🧠.Periop #pembrolizumab (neoadj + adj) + surgery + RT/CRT improves EFS in resectable LA-#….
0
35
0
@TonyFelefly
Tony Felefly
1 month
RT @drmaneesh_singh: Thrilled and Grateful. Our review on metastasis-directed therapy in oligometastatic prostate cancer is now out in Semi….
0
16
0
@TonyFelefly
Tony Felefly
1 month
RT @jryckman3: @TonyFelefly 😃👍.
0
1
0
@TonyFelefly
Tony Felefly
1 month
RT @DrewMoghanaki: Neither surgery nor SBRT is inert. Yet, chest wall pain after surgery is much more severe. Complicating matters, patient….
0
2
0
@TonyFelefly
Tony Felefly
1 month
RT @5_utr: @f2harrell Another reason to embrace longitudinal ordinal models!.
0
7
0